drugset / Trial / NCT01310322

A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

NCT01310322

Phase 1 Completed 12 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

A study in healthy subjects and mild asthmatics to investigate Pharmacokinetics of AZD5423 when administered in different ways.

Timeline

Start
2011-04
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5423 Other / unclassified 250 ug Intravenous
Subject AZD5423 Other / unclassified 300 ug Intravenous
Subject AZD5423 Other / unclassified 1200 ug Intravenous

Indications